| 今开：3.88 | 昨收：3.87 |
| 最高：3.95 | 最低：3.74 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：4.32375256E8 |
Fate Therapeutics(FATE)02-03 05:15
$Fate Therapeutics(FATE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-010491 Size: 5 KB 网页链接查看全文
Fate Therapeutics(FATE)02-10 07:25
$Fate Therapeutics(FATE)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001422848-24-000230 Act: 34 Size: 18 KB 网页链接查看全文
Fate Therapeutics(FATE)02-13 07:15
$Fate Therapeutics(FATE)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000895345-24-000042 Act: 34 Size: 198 KB 网页链接查看全文
Fate Therapeutics(FATE)03-21 05:35
$Fate Therapeutics(FATE)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-24-072868 Act: 33 Size: 566 KB 网页链接查看全文
Fate Therapeutics(FATE)02-27 05:15
$Fate Therapeutics(FATE)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-24-020158 Act: 34 Size: 11 MB 网页链接查看全文
Fate Therapeutics(FATE)03-06 05:25
$Fate Therapeutics(FATE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-025992 Size: 4 KB 网页链接查看全文
Fate Therapeutics(FATE)02-27 05:05
$Fate Therapeutics(FATE)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-24-020123 Act: 34 Size: 403 KB 网页链接查看全文
Fate Therapeutics(FATE)03-26 05:25
$Fate Therapeutics(FATE)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001104659-24-038492 Act: 34 Size: 132 KB 网页链接查看全文
Fate Therapeutics(FATE)02-03 05:15
$Fate Therapeutics(FATE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-010485 Size: 5 KB 网页链接查看全文
Fate Therapeutics(FATE)今天 04:15
$Fate Therapeutics(FATE)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-24-118056 Act: 34 Size: 665 KB 网页链接查看全文
交易追踪 ARK 9月3日共有37笔交易，笔数变化不大，个股成交额有所放大，其中，斥资约4000万美元买入美国流媒体领军者Roku，卖出1900万美元加拿大电商服务平台Shopify。此外，还有买入Fate Therapeutics、卖出Square等标的。ARK基金创始人“... 网页链接
$Fate Therapeutics(FATE)$ ARS Annual Report to Security Holders Accession Number: 0001193125-24-118086 Act: 34 Size: 11 MB 网页链接
$Fate Therapeutics(FATE)$ DEF 14A Other definitive proxy statements Accession Number: 0001193125-24-117981 Act: 34 Size: 3 MB 网页链接
$Fate Therapeutics(FATE)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-24-118056 Act: 34 Size: 665 KB 网页链接
$Fate Therapeutics(FATE)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001193125-24-100748 Act: 33 Size: 395 KB 网页链接
$Fate Therapeutics(FATE)$ PRE 14A Other preliminary proxy statements Accession Number: 0001193125-24-097724 Act: 34 Size: 3 MB 网页链接
$Fate Therapeutics(FATE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-038585 Size: 9 KB 网页链接
$Fate Therapeutics(FATE)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001104659-24-038492 Act: 34 Size: 132 KB 网页链接
$Fate Therapeutics(FATE)$ 8-K Current report, items 1.01, 3.02, 8.01, and 9.01 Accession Number: 0001193125-24-072871 Act: 34 Size: 674 KB 网页链接
$Fate Therapeutics(FATE)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-24-072868 Act: 33 Size: 566 KB 网页链接
$Fate Therapeutics(FATE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-025992 Size: 4 KB 网页链接